BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9261109)

  • 1. Activation of type IV procollagenases by human tumor-associated trypsin-2.
    Sorsa T; Salo T; Koivunen E; Tyynelä J; Konttinen YT; Bergmann U; Tuuttila A; Niemi E; Teronen O; Heikkilä P; Tschesche H; Leinonen J; Osman S; Stenman UH
    J Biol Chem; 1997 Aug; 272(34):21067-74. PubMed ID: 9261109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
    Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
    Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
    Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human matrix metalloproteinases by various bacterial proteinases.
    Okamoto T; Akaike T; Suga M; Tanase S; Horie H; Miyajima S; Ando M; Ichinose Y; Maeda H
    J Biol Chem; 1997 Feb; 272(9):6059-66. PubMed ID: 9038230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
    J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
    Ogata Y; Itoh Y; Nagase H
    J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II.
    Suzuki K; Lees M; Newlands GF; Nagase H; Woolley DE
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):301-6. PubMed ID: 7826345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
    J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
    Benbow U; Butticè G; Nagase H; Kurkinen M
    J Biol Chem; 1996 May; 271(18):10715-22. PubMed ID: 8631880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
    Ogata Y; Enghild JJ; Nagase H
    J Biol Chem; 1992 Feb; 267(6):3581-4. PubMed ID: 1371271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
    Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
    Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
    Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
    J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
    Rao CN; Mohanam S; Puppala A; Rao JS
    Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.